查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1580963

基因型鑒定檢測市場：按產品、技術、樣本類型、應用和最終用戶分類 - 2025-2030 年全球預測

Genotyping Assay Market by Offering (Instruments, Reagents & Kits, Software & Services), Technology (Microarray Analysis, Next-Generation Sequencing, Polymerase Chain Reaction), Sample Type, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年基因型鑒定檢測市值為179.3億美元，預計到2024年將達到204.5億美元，複合年成長率為14.42%，到2030年將達到460.6億美元。

基因型鑒定測定是基因組學和生物技術中的重要工具，對於分析遺傳變異至關重要，並且可以揭示疾病傾向、個人化醫療機會、農業創新等。對基因型鑒定測定的需求源於它們能夠提供對遺傳組成的詳細了解並促進診斷應用、藥物開發和精密農業。應用範圍從幫助識別癌症和心血管疾病等疾病易感性的醫療保健，到提高作物復原力和產量的農業。製藥、診斷、營養基因組學和動物育種等行業廣泛將這些檢測方法用於各種最終用途。

主要市場統計
基準年[2023] 179.3億美元
預測年份 [2024] 204.5億美元
預測年份 [2030] 460.6億美元
複合年成長率（%） 14.42%

關鍵的成長要素包括精準醫療的進步、個人化醫療保健意識的增強以及農業生物技術的創新。基因型鑒定在藥物開發平臺中的日益整合及其在根據個體遺傳特徵量身定做治療方法的關鍵作用正在推動市場成長。由於次世代定序技術的增強以及與生物資訊學的整合以進行更全面的資料分析，基因型鑒定測定市場的擴大是一個新的商機，我們正在創新針對遺傳資料的資料分析解決方案，這將為新興企業開闢一條道路。

然而，與先進基因型鑒定技術相關的高成本、新興市場缺乏意識以及對基因資料保密性的道德擔憂對市場成長構成了挑戰。此外，技術進步的快速發展需要持續的研發投資，這也可能導致敏感的監管障礙。

為了創新，公司可以專注於開發適合已開發市場和新興市場的具有成本效益的攜帶式基因型鑒定平台。結合人工智慧和機器學習來簡化遺傳資料分析並提高預測和解釋的效率和準確性的跨學科研究也具有巨大潛力。基因型鑒定檢測市場的本質是高度動態的，受到快速技術進步的推動，積極主動地解決隱私問題，並強調利用技術協同效應效應的戰略夥伴關係，從而提供巨大的成長機會。

市場動態：揭示快速發展的基因型鑒定檢測市場的關鍵市場洞察

供需的動態交互作用正在改變基因型鑒定檢測市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 個人化醫療需求不斷成長
    • 遺傳病患病率增加
    • 活性化基因型鑒定技術的研發
  • 市場限制因素
    • 維護和操作基因型鑒定設備和測試的成本高昂
  • 市場機會
    • 將基因型鑒定檢測與數位健康平台和電子健康記錄(EHR) 結合
    • 相關人員之間的持續合作
  • 市場挑戰
    • 與基因型鑒定檢測相關的複雜的監管合規性和倫理考慮

波特五力：駕馭基因型鑒定檢測市場的策略工具

波特的五力架構是了解基因型鑒定檢測市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解基因型鑒定檢測市場的外部影響

外部宏觀環境因素在塑造基因型鑒定檢測市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解基因型鑒定檢測市場的競爭格局

基因型鑒定檢測市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣基因型鑒定檢測市場供應商的績效評估

FPNV定位矩陣是評估基因型鑒定檢測市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了基因型鑒定檢測市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，基因型鑒定檢測市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 個人化醫療需求不斷成長
      • 遺傳性疾病增加
      • 增加基因分型技術的研發活動
    • 抑制因素
      • 維護和運行基因分型設備和測試的高成本
    • 機會
      • 將基因分型測試與數位健康平台和電子健康記錄 (EHR) 結合
      • 相關人員之間的持續合作
    • 任務
      • 與基因型鑒定檢測相關的複雜的監管合規性和倫理考慮
  • 市場區隔分析
    • 我們提供什麼：增加研究實驗室和醫院設備的使用，以確保效率和準確性
    • 應用：透過擴大基因分型檢測在農業的應用來提高農業產量
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章基因型鑒定檢測市場：透過提供

  • 裝置
  • 試劑和套件
  • 軟體和服務

第7章基因型鑒定檢測市場：依技術分類

  • 微陣列分析
  • 次世代定序
  • 聚合酵素鏈鎖反應
  • 桑格序列

第 8 章依樣本類型基因型鑒定檢測市場

  • 血液樣本
  • 頰黏膜拭子
  • 唾液樣本
  • 組織樣本

第9章基因型鑒定檢測市場：依應用分類

  • 農業
  • 動物遺傳學
  • 診斷與個人化醫療
  • 藥物基因組學

第 10 章基因型鑒定檢測市場：依最終用戶分類

  • 學術研究所
  • 合約調查機構
  • 醫院/診所
  • 製藥和生物技術公司

第11章美洲基因型鑒定檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太地區基因基因型鑒定檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲/中東/非洲基因型鑒定檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • BD 與 Healthians 合作提高家庭診斷的準確性並擴大印度的服務
    • Thermo Fisher Scientific 推出泛基因組陣列，徹底改變基因組研究與臨床診斷
  • 戰略分析和建議

公司名單

  • 3CR Bioscience Ltd.
  • Azenta Life Sciences
  • Bio-Rad Laboratories, Inc.
  • Chemagen Technologie GmbH
  • Danaher Corporation
  • Eurofins Scientific SE
  • Grifols, SA
  • Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • LGC Biosearch Technologies
  • Mayo Clinic Laboratories
  • NeoGenomics Laboratories, Inc.
  • New England Biolabs, Inc.
  • Novogene Co., Ltd.
  • Oxford Nanopore Technologies PLC.
  • Pacific Biosciences of California, Inc.
  • Paragon Genomics, Inc.
  • Promega Corporation
  • QIAGEN GmbH
  • Standard BioTools Inc.
  • TAKARA BIO INC.
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
Product Code: MRR-4F7B2F382F32

The Genotyping Assay Market was valued at USD 17.93 billion in 2023, expected to reach USD 20.45 billion in 2024, and is projected to grow at a CAGR of 14.42%, to USD 46.06 billion by 2030.

Genotyping assays are critical tools in genomics and biotechnology, essential for analyzing genetic variations that can reveal predispositions to diseases, personalized medicine opportunities, and agricultural innovations. The necessity of genotyping assays stems from their ability to provide detailed insights into genetic compositions, facilitating diagnostic applications, drug development, and precision agriculture. Their applications span across healthcare, where they assist in identifying susceptibilities to diseases like cancer and cardiovascular disorders, and in agriculture, promoting crop resilience and yield. Industries such as pharmaceuticals, diagnostics, nutrigenomics, and animal breeding utilize these assays extensively for varied end-use purposes.

KEY MARKET STATISTICS
Base Year [2023] USD 17.93 billion
Estimated Year [2024] USD 20.45 billion
Forecast Year [2030] USD 46.06 billion
CAGR (%) 14.42%

Key growth influencers include advancements in precision medicine, rising awareness of personalized healthcare, and innovations in agricultural biotechnology. The increasing integration of genotyping in drug development pipelines and its critical role in tailoring therapies to individual genetic profiles propels market growth. Emerging opportunities lie in expanding the genotyping assays market through enhanced next-generation sequencing technologies and integration with bioinformatics for more comprehensive data analysis, creating pathways for startups to innovate in data analytics solutions tailored for genetic data.

However, market growth is challenged by high costs associated with advanced genotyping technologies, lack of awareness in emerging markets, and ethical concerns about genetic data confidentiality. Additionally, the fast-paced technological advancements necessitate continuous investment in R&D and may lead to regulatory hurdles that need careful navigation.

For innovation, businesses can focus on developing cost-effective and portable genotyping platforms suitable for both developed and emerging markets. There's also significant potential in interdisciplinary research, combining AI and machine learning to streamline genetic data analysis, improving the efficiency and accuracy of predictions and interpretations. The nature of the genotyping assay market is highly dynamic, driven by rapid technological advancements, and offers vast opportunities for growth with a proactive stance on addressing privacy concerns and an emphasis on strategic partnerships that leverage technological synergies.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Genotyping Assay Market

The Genotyping Assay Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing demand for personalized medicine
    • Increasing prevalence of genetic disorders
    • Increased research and development activities in genotyping technologies
  • Market Restraints
    • High costs associated with maintaining, and running genotyping equipment and tests
  • Market Opportunities
    • Integration of genotyping assays with digital health platforms and electronic health records (EHRs)
    • Ongoing collaborative activities between stakeholders
  • Market Challenges
    • Complex regulatory compliances and ethical considerations associated with genotyping assay

Porter's Five Forces: A Strategic Tool for Navigating the Genotyping Assay Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Genotyping Assay Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Genotyping Assay Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Genotyping Assay Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Genotyping Assay Market

A detailed market share analysis in the Genotyping Assay Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Genotyping Assay Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Genotyping Assay Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Genotyping Assay Market

A strategic analysis of the Genotyping Assay Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Genotyping Assay Market, highlighting leading vendors and their innovative profiles. These include 3CR Bioscience Ltd., Azenta Life Sciences, Bio-Rad Laboratories, Inc., Chemagen Technologie GmbH, Danaher Corporation, Eurofins Scientific SE, Grifols, S.A., Hoffmann-La Roche Ltd., Illumina, Inc., LGC Biosearch Technologies, Mayo Clinic Laboratories, NeoGenomics Laboratories, Inc., New England Biolabs, Inc., Novogene Co., Ltd., Oxford Nanopore Technologies PLC., Pacific Biosciences of California, Inc., Paragon Genomics, Inc., Promega Corporation, QIAGEN GmbH, Standard BioTools Inc., TAKARA BIO INC., Tecan Trading AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Genotyping Assay Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Offering, market is studied across Instruments, Reagents & Kits, and Software & Services.
  • Based on Technology, market is studied across Microarray Analysis, Next-Generation Sequencing, Polymerase Chain Reaction, and Sanger Sequencing.
  • Based on Sample Type, market is studied across Blood Sample, Buccal Swab, Saliva Sample, and Tissue Sample.
  • Based on Application, market is studied across Agriculture, Animal Genetics, Diagnostics & Personalized Medicine, and Pharmacogenomics.
  • Based on End-User, market is studied across Academic & Research Institutes, Contract Research Organizations, Hospitals & Clinics, and Pharmaceutical & Biotech Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for personalized medicine
      • 5.1.1.2. Increasing prevalence of genetic disorders
      • 5.1.1.3. Increased research and development activities in genotyping technologies
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with maintaining, and running genotyping equipment and tests
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of genotyping assays with digital health platforms and electronic health records (EHRs)
      • 5.1.3.2. Ongoing collaborative activities between stakeholders
    • 5.1.4. Challenges
      • 5.1.4.1. Complex regulatory compliances and ethical considerations associated with genotyping assay
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Offering: Growing usage of instruments in research labs and hospitals for ensuring efficiency and precision
    • 5.2.2. Application: Increasing usage of genotyping assays in agriculture for enhancing agricultural yields
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Genotyping Assay Market, by Offering

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents & Kits
  • 6.4. Software & Services

7. Genotyping Assay Market, by Technology

  • 7.1. Introduction
  • 7.2. Microarray Analysis
  • 7.3. Next-Generation Sequencing
  • 7.4. Polymerase Chain Reaction
  • 7.5. Sanger Sequencing

8. Genotyping Assay Market, by Sample Type

  • 8.1. Introduction
  • 8.2. Blood Sample
  • 8.3. Buccal Swab
  • 8.4. Saliva Sample
  • 8.5. Tissue Sample

9. Genotyping Assay Market, by Application

  • 9.1. Introduction
  • 9.2. Agriculture
  • 9.3. Animal Genetics
  • 9.4. Diagnostics & Personalized Medicine
  • 9.5. Pharmacogenomics

10. Genotyping Assay Market, by End-User

  • 10.1. Introduction
  • 10.2. Academic & Research Institutes
  • 10.3. Contract Research Organizations
  • 10.4. Hospitals & Clinics
  • 10.5. Pharmaceutical & Biotech Companies

11. Americas Genotyping Assay Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Genotyping Assay Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Genotyping Assay Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. BD Partners with Healthians to Boost Home Diagnostic Accuracy and Expand Services in India
    • 14.3.2. Thermo Fisher Scientific Launches Pangenomix Array to Revolutionize Genomic Research and Clinical Diagnostics
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3CR Bioscience Ltd.
  • 2. Azenta Life Sciences
  • 3. Bio-Rad Laboratories, Inc.
  • 4. Chemagen Technologie GmbH
  • 5. Danaher Corporation
  • 6. Eurofins Scientific SE
  • 7. Grifols, S.A.
  • 8. Hoffmann-La Roche Ltd.
  • 9. Illumina, Inc.
  • 10. LGC Biosearch Technologies
  • 11. Mayo Clinic Laboratories
  • 12. NeoGenomics Laboratories, Inc.
  • 13. New England Biolabs, Inc.
  • 14. Novogene Co., Ltd.
  • 15. Oxford Nanopore Technologies PLC.
  • 16. Pacific Biosciences of California, Inc.
  • 17. Paragon Genomics, Inc.
  • 18. Promega Corporation
  • 19. QIAGEN GmbH
  • 20. Standard BioTools Inc.
  • 21. TAKARA BIO INC.
  • 22. Tecan Trading AG
  • 23. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GENOTYPING ASSAY MARKET RESEARCH PROCESS
  • FIGURE 2. GENOTYPING ASSAY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GENOTYPING ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES GENOTYPING ASSAY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES GENOTYPING ASSAY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. GENOTYPING ASSAY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. GENOTYPING ASSAY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GENOTYPING ASSAY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GENOTYPING ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GENOTYPING ASSAY MARKET DYNAMICS
  • TABLE 7. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY MICROARRAY ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY BLOOD SAMPLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY BUCCAL SWAB, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY SALIVA SAMPLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY TISSUE SAMPLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY ANIMAL GENETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY DIAGNOSTICS & PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES GENOTYPING ASSAY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDIA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. INDONESIA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. JAPAN GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. MALAYSIA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. PHILIPPINES GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. SINGAPORE GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. SOUTH KOREA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. TAIWAN GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. THAILAND GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. VIETNAM GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. DENMARK GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. EGYPT GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. FINLAND GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. FRANCE GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. GERMANY GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. ISRAEL GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. ITALY GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. NETHERLANDS GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. NIGERIA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. NORWAY GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. POLAND GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. QATAR GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. RUSSIA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. SAUDI ARABIA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH AFRICA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. SPAIN GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWEDEN GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. SWITZERLAND GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. TURKEY GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 240. GENOTYPING ASSAY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 241. GENOTYPING ASSAY MARKET, FPNV POSITIONING MATRIX, 2023